{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:18:14Z","timestamp":1782238694133,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ijantimicag.2022.106522","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T07:08:28Z","timestamp":1642230508000},"page":"106522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of penicillin\u2010gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8933-2954","authenticated-orcid":false,"given":"Lauren","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-8602","authenticated-orcid":false,"given":"Ashley","family":"Milkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-8552","authenticated-orcid":false,"given":"Lauren","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Everson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106522_bib0001","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cpcardiol.2005.12.001","article-title":"Update on infective endocarditis","volume":"31","author":"Bashore","year":"2006","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106522_bib0003","article-title":"Treatment of infective endocarditis","volume":"32","author":"Pound","year":"2007","journal-title":"US Pharm"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.me.34.020183.002213","article-title":"Antibiotic treatment of infective endocarditis","volume":"34","author":"Wilson","year":"1983","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0005","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone","volume":"146","author":"Gavald\u00e1","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/594122","article-title":"Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients","volume":"48","author":"Buchholtz","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0007","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","article-title":"Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome","volume":"127","author":"Dahl","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijantimicag.2022.106522_bib0008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/338233","article-title":"Enterococcal endocarditis in Sweden, 1995\u20131999: can shorter therapy with aminoglycosides be used?","volume":"34","author":"Olaison","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ijantimicag.2022.106522_bib0009","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1128\/AAC.34.12.2387","article-title":"Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis","volume":"34","author":"Fantin","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jac\/39.4.519","article-title":"Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis","volume":"39","author":"Marangos","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.ijantimicag.2022.106522_bib0011","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis","volume":"56","author":"Fern\u00e1ndez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ijantimicag.2022.106522_bib0012","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/1469-0691.12756","article-title":"Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone","volume":"20","author":"Pericas","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0013","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/jac\/dku004","article-title":"Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5-year comparison with conventional therapy","volume":"69","author":"Cer\u03ccn","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0014","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jinf.2018.06.013","article-title":"Comparison of dual \u03b2-lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis","volume":"77","author":"Rafei","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0015","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/AAC.39.9.1984","article-title":"Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis","volume":"39","author":"Mainardi","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0016","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0017","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106522_bib0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method for classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"issue":"11","key":"10.1016\/j.ijantimicag.2022.106522_bib0019","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2022.106522_bib0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0021","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMcp1206782","article-title":"Infective endocarditis","volume":"368","author":"Hoen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0022","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/431590","article-title":"Repeat infective endocarditis: differentiating relapse from reinfection","volume":"41","author":"Chu","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijantimicag.2022.106522_bib0023","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ijantimicag.2022.106522_bib0024","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/infdis\/153.6.1062","article-title":"A model for predicting nephrotoxicity in patients treated with aminoglycosides","volume":"153","author":"Sawyers","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0025","series-title":"National Cardiological Treatment Guide","first-page":"1","article-title":"Infectious endocarditis:","author":"Moser","year":"2020"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0026","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/infdis\/173.4.909","article-title":"Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents","volume":"173","author":"Brandt","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijantimicag.2022.106522_bib0027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.43.3.639","article-title":"Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides","volume":"43","author":"Gavald\u00e1","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijantimicag.2022.106522_bib0028","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1060028017692357","article-title":"Combination of ceftriaxone and ampicillin for the treatment of enterococcal endocarditis: a qualitative systematic review","volume":"51","author":"Peterson","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2022.106522_bib0029","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.113.002431","article-title":"A new era for treating Enterococcus faecalis endocarditis ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: that is the question!","volume":"127","author":"Miro","year":"2013","journal-title":"Circulation"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:26:40Z","timestamp":1741346800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857922000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0924857922000127"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106522","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of penicillin\u2010gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106522"}}